Evidence map›Paper›PMID 41125295›Full record

ReviewBMJ global health2025

Stakeholder analysis for 'One Health' approach to tackle antimicrobial resistance.

Sanjib Adhikari, Komal Raj Rijal, Daniel M Parker, Prakash Ghimire, Phaik Yeong Cheah, Bipin Adhikari

Abstract readReview
In one paragraph

Review in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sanjib AdhikariCentral Department of Microbiology, Tribhuvan University, Kirtipur, Nepal.
Komal Raj RijalCentral Department of Microbiology, Tribhuvan University, Kirtipur, Nepal.
Daniel M ParkerDepartment of Population Health and Disease Prevention, Joe C. Wen School of Population and Public Health, University of California, Irvine, California, USA.ORCID 0000-0002-5352-7338
Prakash GhimireCentral Department of Microbiology, Tribhuvan University, Kirtipur, Nepal.ORCID 0000-0003-2503-412X
Phaik Yeong CheahCenter for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-6327-3266
Bipin AdhikariCenter for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK Bipin@tropmedres.ac.ORCID 0000-0001-8981-3910

Funding

Wellcome Trust
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) and interventions to mitigate it are multisectoral, exhibiting super-wicked features that require intersectoral collaboration and synergy. Although AMR and mitigation strategies are pressing issues, their solutions are complex, ethically challenging, multilayered and often conflict at various levels and among diverse stakeholders. The main objective of this study was to identify the values and potential contributions of stakeholder analysis related to AMR and potential interventions from a case study that is being undertaken in Nepal using a 'One Health' approach. A total of 33 representatives from human, animal, agricultural and environmental sectors attended a stakeholder meeting in Kathmandu to discuss AMR, its ethical and practical challenges, opportunities and potential interventions. Using a five-pillar framework for stakeholder analysis, we demonstrate its relevance for addressing AMR and propose practical considerations for implementing effective interventions in Nepal. Beyond the practical discussions on AMR and its interventions at the policy, implementation and practice levels, this study underscores the critical value of its methodological reflections for informing ongoing interventions both within Nepal and in similar contexts globally.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, MicrobialOne HealthStakeholder ParticipationAnimalsHumansNepalAnti-Bacterial AgentsGlobal HealthHealth policies and all other topicsHealth systemsMedical microbiology

Identifiers

PMID41125295
PMCPMC12548578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.